Related Experiment Video
Updated: Sep 25, 2026
Detection of Functional Matrix Metalloproteinases by Zymography
Published on: November 9, 2010
Detection and localization of mRNAs encoding matrix metalloproteinases and their tissue inhibitor in human breast
Abstract:
Matrix metalloproteinases (MMPs) are a group of enzymes thought to be responsible for both normal connective-tissue-matrix remodelling and the accelerated breakdown associated with tumor development. These MMPs and tissue inhibitor of MMPs (TIMP1) could be expressed by either the cancer or the stromal cells. Expression of mRNAs encoding interstitial collagenase (MMP1), 72-kD type IV collagenase (MMP2) and stromelysin (MMP3), which are probably involved in tumor invasion and metastasis, and of TIMP1 were studied in human mammary pathology by in situ hybridization and Northern blot analysis. Out of 6 benign lesions, 2 expressed MMP2 mRNAs. mRNAs encoding MMP1 and MMP3 were detectable in occasional stromal and tumor cells in 2 out of 17 carcinomas. Thirteen out of 17 cancers expressed MMP2 mRNA throughout the tumor in stromal cells close to noninvasive tumor clusters and well-differentiated invasive cancer cells. TIMP1 mRNA expression was detected in noninvasive and well-differentiated invasive tumor cells. These data suggest that there is a cooperation between tumor and stromal cells, in particular for the production of 72-kD type IV collagenase, involved in the disruption of basement membranes. A lack of TIMP1 expression from invasive cancer cells would also contribute to matrix destruction.
Insights
Matrix metalloproteinases (MMPs) and tissue inhibitor of MMPs (TIMP1) are key in cancer. This study shows MMP2 cooperation between tumor and stromal cells aids basement membrane disruption in human breast cancer.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Matrix metalloproteinases (MMPs) are enzymes involved in connective tissue remodeling and tumor progression.
- Both cancer cells and stromal cells can express MMPs and their inhibitors, tissue inhibitor of matrix metalloproteinases (TIMP1).
- Specific MMPs like MMP1, MMP2, and MMP3 are implicated in tumor invasion and metastasis.
Purpose of the Study:
- To investigate the expression of MMP1, MMP2, MMP3, and TIMP1 mRNAs in human mammary pathology.
- To understand the roles of these molecules in tumor development, invasion, and metastasis.
- To explore potential cooperation between tumor and stromal cells in matrix degradation.
Main Methods:
- In situ hybridization was used to detect mRNA expression.
- Northern blot analysis was employed for mRNA quantification.
- Human mammary tissue samples, including benign lesions and carcinomas, were analyzed.
Main Results:
- MMP2 mRNA was detected in 2 of 6 benign lesions.
- MMP1 and MMP3 mRNAs were found in occasional stromal and tumor cells in 2 of 17 carcinomas.
- MMP2 mRNA was expressed in stromal cells in 13 of 17 cancers, particularly near tumor clusters and invasive cells.
- TIMP1 mRNA was observed in noninvasive and well-differentiated invasive tumor cells.
Conclusions:
- Cooperation between tumor and stromal cells, especially in producing MMP2, is crucial for basement membrane disruption.
- The observed expression patterns suggest MMP2's role in invasion and metastasis.
- A potential lack of TIMP1 expression by invasive cancer cells may contribute to matrix destruction.
